| HS Code | 316677 |
| Density | 1.02 g/cm³ |
| Melting Point Dsc | 170 °C |
| Vicat Softening Temperature 50 N | 140 °C |
| Water Absorption At 24 H 23 C | 0.7 % |
| Water Absorption At Saturation 23 C | 1.1 % |
| Tensile Yield Stress | 35 MPa |
| Elongation At Break | >300 % |
| Flexural Modulus | 400 MPa |
| Izod Notched Impact Strength 23 C | No break |
| Shore D Hardness | 55 |
As an accredited Arkema Rilsamid AESNO MED Nylon 12 factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Arkema Rilsamid AESNO MED Nylon 12 is supplied as translucent pellets in sealed 25 kg polyethylene bags, ensuring purity and moisture protection. |
| Container Loading (20′ FCL) | 20′ FCL container loaded with Arkema Rilsamid AESNO MED Nylon 12, secured and protected for safe maritime transport. |
| Shipping | Ship as dry, non-hazardous polymer granules in sealed original bags or moisture-barrier packaging. Avoid exposure to humidity, direct sunlight, and temperatures above 40°C. Use standard clean, dry containers or covered trucks, protected from mechanical damage. Keep away from ignition sources. Store cool and dry; handle with care. |
| Storage | Store Arkema Rilsamid AESNO MED Nylon 12 in its original, unopened packaging in a cool, dry, well-ventilated area. Protect from direct sunlight, heat sources, and moisture. Keep containers tightly sealed when not in use to prevent contamination and water absorption. Ideal temperature: below 30°C. Avoid exposure to incompatible chemicals. |
| Shelf Life | Store unopened in a cool, dry place. Shelf life is typically 2 years from production date when properly sealed. |
At the crosshead of a multi-lumen coextrusion line, the specification change from a polyurethane inner layer to Rilsamid AESNO MED alters the drawdown limit at wall sections below 0.35 mm because the polyamide 12 melt exhibits a sharper viscosity-temperature response. The material is dried in a desiccant dryer at 80°C for 4 h to 6 h with a dew point below -30°C; residual moisture must remain below 0.1%, as higher moisture produces micro-voids that reduce burst pressure after gamma irradiation. A single-screw extruder with an L/D of 24:1 and a compression ratio of 2.5:1 is used. The feed, compression, metering, and die zones are set at 200°C, 230°C, 240°C, and 245°C, respectively. The melt enters a coextrusion crosshead with a conical mandrel and a die gap of 0.4 mm; lumens are formed by air injection at 15 kPa to 25 kPa through stainless steel mandrels with an outer diameter of 0.8 mm. Vacuum sizer pressure is maintained at -30 kPa to -45 kPa to control ovality within ±0.04 mm. Quench water temperature is held at 18°C to 22°C. A laser micrometer loop slaved to the puller controls the outside diameter to ±0.03 mm. The terminal extruded product is a triple-lumen central venous catheter shaft that is butt-joined to a polyamide 12 Luer hub. Biological evaluation for the finished shaft follows ISO 10993-5:2009, ISO 10993-10:2010, and USP <88> Class VI. The primary production failure modes are melt fracture at high drawdown, lumen collapse at drawdown ratios exceeding 3.2:1, and mandrel vibration when haul-off speed exceeds 45 m/min for a 2.0 mm outside diameter shaft.
Gate freeze time in thin-walled AESNO MED Luer bodies is governed by spherulite growth at the gate land, which responds directly to mould temperature and gate diameter. On an all-electric press with 600 kN clamp force, a 0.8 mm diameter tunnel gate freezes in 1.2 s at a mould temperature of 50°C; at 70°C the freeze time extends to 2.4 s, and the part shows greater crystallinity by differential scanning calorimetry according to ISO 11357-3:2018. Melt temperature is set at 240°C to 250°C and the hot runner manifold at 255°C. For a single 1.0 g Luer body, fill time is 0.35 s to 0.50 s, and screw recovery completes before the cooling timer ends. Switchover occurs at 97% of shot volume. Hold pressure is 900 bar for 3 s; below 800 bar sink marks appear at the root of the 6% Luer taper. The core pin is vapour-deposited with a 250 µm chromium nitride layer to assist release without external mould release sprays. Dimensional acceptance is based on ISO 80369-7:2021 for small-bore connectors, including the 6% taper, leak tightness, and torque characteristics. The moulded connectors are annealed at 60°C for 2 h in a forced-air oven to stabilise post-mould shrinkage. The terminal product is a rigid Luer lock adapter for enteral feeding sets and IV stopcocks. The upper melt temperature is 260°C; above this threshold, volatilisation of the plasticiser contaminates the core and raises gate blush.
| Standard / method | Requirement assessed |
|---|---|
| ISO 10993-5:2009 | In vitro cytotoxicity using MEM elution; reactivity not exceeding grade 2 |
| ISO 10993-10:2010 | Skin sensitisation; no erythema or oedema greater than blank control |
| USP <88> Class VI | Systemic injection and intracutaneous reactivity tests on raw material or finished component |
| ISO 13485:2016 | Quality management system for medical device manufacturing and traceability |
| ISO 80369-7:2021 | Small-bore connector dimensional, torque, leak, and disconnect performance |
| ISO 11357-3:2018 | Differential scanning calorimetry for crystallinity shift after annealing |
Immediately after moulding, gamma-sterilised stopcocks and Y-connectors are annealed at 60°C for 2 h to complete secondary crystallisation before assembly. Without this step, a sterilisation dose of 25 kGy to 40 kGy can generate trapped free radicals that recombine slowly over 72 h, producing a detectable shift in the interference fit between the tapered male Luer and the mating female body. The stopcock body is moulded from AESNO MED and assembled with a high-density polyethylene stem, which retains torque without external lubricant. The mould uses a ring gate to avoid weld lines at the fluid port. Cavity pressure sensors record a peak of 650 bar at the gate, falling to 250 bar at the end of fill; a pressure deficit above 150 bar indicates premature freeze-off and correlates with later torque drift. Design verification testing for torque follows ISO 80369-7:2021 Annex B, with break-loose torque measured after sterilisation and after accelerated ageing at 55°C for 12 weeks. The operational boundary is the lower plasticiser content at the surface; solvent wiping with isopropyl alcohol above 70% concentration can remove surface plasticiser and increase tack. The terminal product is a medical three-way stopcock used in blood pressure monitoring, anaesthesia, and infusion therapy. The grade is specified because the plasticiser package reduces the brittle failure exhibited by unplasticised PA12 when the gamma dose exceeds 45 kGy.
Reusable surgical handpieces and powered instrument shells that are subjected to pre-vacuum steam cycles between cases impose a combined moisture, pressure, and temperature requirement that polycarbonate often fails through stress-crack formation. AESNO MED is selected for the clamshell housing because the polyamide 12 melt solidifies into a semi-crystalline structure that retains clamp force after repeated exposure to 132°C saturated steam at 2.1 bar. Moulding is performed at a melt temperature of 245°C and a mould temperature of 60°C; the cavity is packed at 1,000 bar to eliminate micro-porosity adjacent to the ultrasonic weld bead. After moulding, the parts are annealed at 80°C for 4 h under nitrogen to prevent oxidative discolouration. In service, the assembled shell is sterilised in a pre-vacuum cycle at 132°C for 4 min, followed by 20 min of vacuum drying. Validation includes ISO 17665-1:2006 for moist heat sterilisation and ISO 10993-12:2021 for extractables after 50 cycles. The production failure mode is warping of the shell when moulded-in residual stress exceeds 8 MPa, assessed by photoelastic inspection; cooling-rate ramps below the glass transition are adjusted to avoid this. The terminal product is a reusable orthopaedic drill handpiece shell. The material should not be exposed to hydrogen peroxide gas plasma at concentrations above 59%, because the plasticiser package can undergo oxidative chain scission.
For dry powder inhaler chassis components and clip-in retention arms, the wall stock is specified at 1.0 mm and snap-fit arms must maintain closure force after drop testing at -20°C. AESNO MED is used for the chassis because the plasticiser package lowers the glass transition temperature sufficiently to avoid the sharp ductile-to-brittle transition observed in unplasticised PA12 between -10°C and 0°C. The mould is a two-plate, 8-cavity tool with a cold runner; the runner diameter is 3.0 mm, and the gate is a 0.6 mm edge gate. Melt temperature is 235°C, mould temperature is 40°C, and hold pressure is 600 bar for 2.5 s. The snap-fit is cycled to 50,000 cycles on a pneumatic press; closure force retention is measured with a load cell and must remain above 80% of the initial value. Dimensional tolerance on the split line is held to ±0.05 mm after post-moulding conditioning for 48 h at 23°C and 50% relative humidity. The terminal product is an inhaler base chassis for dry powder and pressurised metered-dose devices. Published consolidated data for this specific inhaler chassis configuration is limited; converters should verify snap-fit geometry on their own tool and conduct extraction testing under ISO 10993-12:2021 if the device mouthpiece is in continuous contact with the drug formulation.
Wearable insulin pump belt clips, continuous glucose monitor housings, and mounting brackets for ambulatory infusion pumps are moulded from AESNO MED when glass fibre reinforcement would abrade textile belts and create patient discomfort. The unfilled grade retains sufficient rigidity for snap assembly while eliminating the anisotropic warpage associated with glass-filled PA12. Injection moulding uses a melt temperature of 240°C and a mould temperature of 50°C; when the mould temperature is allowed to fall below 40°C, the living hinge becomes quenched and loses flexural fatigue life. The mould shrinkage after 24 h is 1.4% to 1.8%, measured according to ISO 294-4. The living hinge is designed with a thickness of 0.25 mm to 0.30 mm; hinge bending fatigue is verified on a custom flex tester at 1 Hz for 100,000 cycles. The clips are assembled onto injection-moulded chassis plates with stainless steel pins; hinge pin torque retention is measured at 0.2 N·m to 0.6 N·m. The terminal product is a belt clip for a wearable insulin pump, tested to IEC 60601-1-11:2015 for mechanical robustness in home healthcare environments. The material boundary is that prolonged contact with insect repellent containing DEET above 30% swells the surface and reduces the clip clamping force; a protective overmould or periodic replacement is specified.
To transmit rotational force along a steerable diagnostic catheter shaft without delaminating from the wire braid, AESNO MED is pressure-extruded as a 0.15 mm jacket over a AISI 304V stainless steel braid, using a pressure extrusion die with a land length of 2.0 mm and a draw-down ratio of 1.8:1. The melt temperature at the die is 245°C; the core tube is preheated to 120°C before entering the crosshead to promote interfacial adhesion. Line speed is set to 25 m/min for a 2.7 mm outside diameter shaft. After cooling in a water bath at 15°C to 20°C, the jacket is inspected for pinholes using a 3 kV spark tester. Torque transfer is measured on a custom bench fixture; a 1:1 input-to-output rotation ratio must be maintained up to 5 N·cm torque. The terminal product is a steerable electrophysiology diagnostic catheter. The main processing failure is interlaminar void formation when the die temperature drops below 235°C or when moisture in the nylon exceeds 0.08% at the crosshead.
Competitive Arkema Rilsamid AESNO MED Nylon 12 prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Arkema Rilsamid AESNO MED Nylon 12 is an unfilled, natural-colour polyamide 12 resin supplied in pellet form for injection moulding and extrusion of medical device components. The base polymer is a semi-crystalline homopolymer of lauryllactam; its lower amide-group density compared with polyamide 6 or polyamide 66 gives a density of 1.01–1.02 g/cm³ when measured to ISO 1183-1:2019 and a saturation water absorption in 23 °C water of approximately 1.1 % when tested to ISO 62:2008. The MED designation does not indicate a different melting point from standard PA12; it indicates that the production stream is managed under medical-change-control documentation and that the supplier has generated regulatory support data for biocompatibility assessment. The resin is documented for evaluation under ISO 10993-1:2018 and for Class VI testing defined in USP <88>. Finished-device biocompatibility is not transferred by the resin supplier; it remains a design-validation activity under ISO 14971:2019 risk-management procedures.
The medium-viscosity base sets AESNO MED apart from low-viscosity flow-optimised PA12 grades; it is better suited to extrusion and thick-section injection moulding than to ultra-thin-wall high-flow moulding. In comparison with PA6 and PA66, the practical difference is moisture-driven dimensional movement. PA6 specimens exposed to 23 °C/50 % RH can absorb 2.5–3.5 % moisture, while PA12 under the same condition absorbs approximately 0.7–0.9 %; this lower uptake reduces tensile-modulus drift and length change in humid service. Relative to Rilsan PA11, Rilsamid AESNO MED typically shows a melting point near 172–176 °C instead of 185–190 °C, allowing a lower melt-temperature profile and less thermal stress on heat-sensitive co-extruded thermoplastic elastomer layers. The material is unfilled; flexural modulus is therefore much lower than that of 30 % glass-fibre-filled PA12 grades, which can reach 6000–7000 MPa under ISO 178:2019, while AESNO MED remains near 1100–1400 MPa. That lower stiffness is offset by higher elongation and better stress-cracking resistance in press-fit and snap-fit geometries.
Representative values from published technical data are consolidated below. They are dry-as-moulded or conditioned as indicated and should be replaced by lot-specific measurements for process qualification.
| Property | Test method | Representative range/value |
|---|---|---|
| Density | ISO 1183-1:2019 | 1.01–1.02 g/cm³ |
| Tensile modulus, 1 mm/min | ISO 527-1/-2 | 1200–1500 MPa |
| Tensile stress at yield | ISO 527-1/-2 | 42–48 MPa |
| Nominal strain at break | ISO 527-1/-2 | >50 % |
| Flexural modulus | ISO 178:2019 | 1100–1400 MPa |
| Charpy notched impact at 23 °C | ISO 179-1/1eA | 5–9 kJ/m² |
| Melting temperature, 10 °C/min | ISO 11357-1/-3 | 172–176 °C |
| Vicat softening temperature B50 | ISO 306 | 162–168 °C |
| Heat deflection temperature 0.45 MPa | ISO 75-1/-2 | 125–135 °C |
| Water absorption at saturation, 23 °C water | ISO 62:2008 | 1.0–1.2 % |
The mechanical values in the table are sensitive to moisture conditioning. When tensile bars are moulded dry and then conditioned to 23 °C/50 % RH, tensile modulus falls by roughly 5–15 %, while nominal strain at break increases. This test-condition dependence is defined by ISO 1110, which describes accelerated conditioning of polyamides; designers should specify whether values refer to dry-as-moulded or conditioned specimens when comparing PA12 grades.
For injection moulding of multi-lumen catheter hubs, a three-zone general-purpose screw with L/D 20:1–24:1 and compression ratio 2.5:1–3.0:1 is used. Melt temperature should be held at 230–250 °C, with the nozzle upper limit at 255 °C to limit thermo-oxidative yellowing. Mould temperature is typically set from 40 °C to 80 °C; higher mould temperatures increase crystallinity and dimensional stability, while lower temperatures reduce cycle time but raise residual stress. Pre-drying in a desiccant-bed dryer at 80 °C for 4–6 h is required when the material has been exposed to relative humidity above 60 %. A return-air dew point at or below -30 °C is needed to reduce pellet moisture to ≤0.10 % by weight. Residual moisture above 0.15 % causes hydrolytic chain scission during plastication, with associated silver streaking, melt-viscosity loss, and reduced weld-line strength. Hot-air drying alone is generally insufficient at high ambient humidity; vacuum venting at -0.06 MPa to -0.08 MPa should be used for extrusion when a vented barrel is available.
EtO sterilisation validated to ISO 11135:2014 introduces no significant thermal load; the dimensional change of PA12 is typically less than 1 % after one standard cycle followed by aeration. Gamma sterilisation at 25–40 kGy shifts colour toward yellow and reduces impact strength because of oxidative chain scission; the effect is dose-dependent and lower than that seen in polypropylene but greater than that seen in polyaryletherketones. Steam sterilisation at 121 °C for 15 min per ISO 17665-1:2006 is acceptable for limited cycles, but repeated autoclaving at 134 °C is not recommended because saturated steam accelerates hydrolysis of the amide bond. At cumulative wet-heat exposure above approximately 100–150 h, tensile elongation drops and surface embrittlement can occur; parts under hoop stress, such as luer-collar retention features, should be subjected to cycle-life preconditioning with mechanical testing after 50 sterilisation cycles.
A compliance matrix for Rilsamid AESNO MED should distinguish resin-level documentation from finished-device obligations.
| Document/Requirement | Designation | Relevance |
|---|---|---|
| Biocompatibility evaluation | ISO 10993-1:2018 | Basis for biological endpoint selection; final device validation remains with the manufacturer |
| USP biological reactivity | USP <88> | Class VI test support for systemic injection, intracutaneous, and implantation endpoints |
| Quality management | ISO 13485:2016 | Supplier site quality system; not a material property |
| EtO sterilisation | ISO 11135:2014 | Common terminal sterilisation for catheter and drug-delivery components |
| Moist heat sterilisation | ISO 17665-1:2006 | Limited-cycle steam sterilisation at 121 °C |
| Risk management | ISO 14971:2019 | Finished-device risk assessment required |
| EU chemical regulation | REACH Regulation (EC) No 1907/2006 | Resin registration and article communication obligations in the EU |
| RoHS restricted substances | Directive 2011/65/EU | No lead, mercury, cadmium, hexavalent chromium, PBB, or PBDE above applicable limits |
Extrusion of single-lumen microbore tubing from AESNO MED commonly uses a barrier screw with L/D ≥ 24:1, a screen pack configured as 60/80/100 mesh, and a gear pump set to maintain die pressure within ±0.3 MPa. A draw ratio between 1.5:1 and 3:1 is selected to control orientation; excessive draw raises axial strength but reduces hoop-stress burst resistance. The extrudate is cooled in a water trough at 35–50 °C and then conditioned at 23 °C/50 % RH for 48–72 h before final dimension inspection because PA12 can shrink by 0.4–0.8 % during moisture equilibration. Plasma or corona surface treatment before bonding can be required because PA12 has a lower surface energy than PA6; untreated extrusion surfaces may fail pull-off tests on solvent-bonded or UV-cured joints.
The product is used for male and female luer connectors under ISO 80369-7:2016, where dimensional tolerance is specified at the sub-millimetre level and where creep under continuous pressure must be characterized. PA12 with moisture uptake below 1 % maintains a dimensional shift low enough that a 6 % interference ring in a luer can retain function after 72 h at 37 °C in saline. PA6 plasticises further and can exhibit greater creep under the same load; this is the practical reason PA12 is selected for fluid-contact fittings. The material is not suitable for prolonged contact with strong alkaline solutions such as 10 % NaOH at elevated temperature, which attack the polyamide chain. Concentrated formic acid, hydrochloric acid, and heated oxidisers must likewise be avoided.